Label: RECTAEASE HEMORRHOID RELIEF CREAM- lidocaine cream
- NDC Code(s): 69396-070-01
- Packager: Trifecta Pharmaceuticals USA LLC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated February 27, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Drug Facts
- Active Ingredient
- Purpose
- Uses
- Warning Section
- Stop use and ask a doctor
- When using this product
- If Pregnant or Breast Feeding
- Keep out of reach of children
-
Directions
Directions:
When practical, clean the affected area with mild soaping warm water and rinse thoroughly.
Gently dry by patting or blotting with a toilet tissue or soft cloth before applying.
Adult and children 12 years of age and older, apply to affected area not more than 6 times a day.
Children under 12 years of age: do not use, ask a doctor
- Other Information
- Inactive Ingredients
- Questions or Comments
- Distributed By
- Packaging
-
INGREDIENTS AND APPEARANCE
RECTAEASE HEMORRHOID RELIEF CREAM
lidocaine creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:69396-070 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE 50 mg in 1 g Inactive Ingredients Ingredient Name Strength POLYSORBATE 80 (UNII: 6OZP39ZG8H) HYDROGENATED SOYBEAN LECITHIN (UNII: H1109Z9J4N) BENZYL ALCOHOL (UNII: LKG8494WBH) PROPYLENE GLYCOL (UNII: 6DC9Q167V3) WATER (UNII: 059QF0KO0R) ALPHA-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0) CHOLESTEROL (UNII: 97C5T2UQ7J) TROLAMINE (UNII: 9O3K93S3TK) ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS) CARBOMER 940 (UNII: 4Q93RCW27E) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:69396-070-01 1 in 1 BOX 04/19/2021 1 28 g in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M015 04/19/2021 Labeler - Trifecta Pharmaceuticals USA LLC (079424163)